Research programme: plasminogen activator inhibitor-1 inhibitors - XenovaAlternative Names: PAI-1; PAI-1 inhibitors - Xenova; XR334 series - Xenova
Latest Information Update: 12 Apr 2006
At a glance
- Originator Xenova Group
- Class Small molecules
- Mechanism of Action Plasminogen activator inhibitor-1 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer; Thrombosis